EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel flavone derivatives as aldose reductase inhibitors with anti-cataract potential using goat lens

Manickam Vijayabaskaran, Elangovan Kapemeyar, Arumugam Madeswaran

Letters in Drug Design & Discovery · 2025-11 · 22 (11) · 100247

DOI: 10.1016/j.lddd.2025.100247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2025-11. Verfasst von Manickam Vijayabaskaran und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cataract is one of the primary causes of visual impairment in diabetics. Flavonoids have a wide range of biological activities linked to human health in addition to their primary antioxidant property. The current study aims to predict the aldose reductase inhibition by in silico drug likeness and molecular docking studies of some synthesized flavone derivatives and evaluate the activity anti-cataract activity of synthesized derivatives using in vitro using goat lenses. The drug likeness and in silico docking studies were performed for twenty flavone derivatives using Molinspiration software and AutoDock 4.2. Based on the docking score and docking orientations, the five flavone derivatives were selected for the synthesis. The physical data and characterization of FC7 and FC8 flavone derivatives were carried out using Infrared and Mass spectroscopy. The in vitro glucose-induced cataract in goat lens studies was carried out for FC7 and FC8. In results, comparing the chosen flavone derivatives to other flavone derivatives, F1, F2, FC7, FC8, and FC10 demonstrated exceptionally high binding energies in the range of −8.14 to −7.64 kcal/mol. The chosen flavone compounds showed noteworthy inhibitory capability against the aldose reductase enzyme. In the characterization, the results further validate that the synthesised molecules of FC7 and FC8 structures as 4′-hydroxyflavone and 4′- methoxyflavone. 4′-Hydroxyflavone treated lens reversed the glucose-induced cataract and increased the number of squares covered in the graph which in turn reduced the opacification of lens when compared to all other groups. It can be concluded that, 4′-Hydroxyflavone has potential role in the prevention of cataract and Diabetic retinopathy. From the current studies we found that 4′-Hydroxyflavone has anti-cataract activity and further preclinical and clinical studies required to prove its role in the management of diabetic retinopathy.

Zitieren

APA

Vijayabaskaran, M., Kapemeyar, E., & Madeswaran, A. (2025). Novel flavone derivatives as aldose reductase inhibitors with anti-cataract potential using goat lens. Letters in Drug Design & Discovery, 22(11), 100247. https://doi.org/10.1016/j.lddd.2025.100247

Vancouver

Vijayabaskaran M, Kapemeyar E, Madeswaran A. Novel flavone derivatives as aldose reductase inhibitors with anti-cataract potential using goat lens. Letters in Drug Design & Discovery. 2025;22(11):100247. doi:10.1016/j.lddd.2025.100247

BibTeX
@article{Vijayabaskaran2025,
  author = {Vijayabaskaran, Manickam and Kapemeyar, Elangovan and Madeswaran, Arumugam},
  title = {Novel flavone derivatives as aldose reductase inhibitors with anti-cataract potential using goat lens},
  journal = {Letters in Drug Design & Discovery},
  year = {2025},
  volume = {22},
  number = {11},
  pages = {100247},
  doi = {10.1016/j.lddd.2025.100247}
}
Kostenlos starten →